cyclomethycaine

This page covers all cyclomethycaine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Sodium channel alpha subunits; brain (Types I, II, III).

Targets

Sodium channel alpha subunits; brain (Types I, II, III)

Phase 2 pipeline (1)

• Topocaine · Neuroscience
  Topocaine blocks sodium channels in the brain to prevent pain signals from being transmitted.

Patent intelligence

• cyclomethycaine patent landscape — aggregated cliff calendar, attackable patents, originator estates